Abstract
Eighteen patients with primary abnormalities of neutrophil chemotaxis are described. The most common clinical presentation was one of recurrent upper respiratory tract infection (nine patients) or recurrent pyoderma (seven patients), and two children had a history of oropharyngeal candidiasis and recurrent skin sepsis. Of these eighteen patients, sixteen had intrinsic polymorphonuclear leucocyte (PMN) defects as shown by diminished random migration and movement towards endotoxin-activated serum. PMN chemotaxis towards casein was, however, normal. In nine out of the latter patients, there was an associated inability of the serum to generate chemotactic factors. PMN from two adult patients, both suffering from recurrent boils, moved normally both in random and directed systems, but sera from these patients contained heat-stable inhibitors of neutrophil chemotaxis. In vitro levamisole treatment (10(-3) M) markedly improved the PMN function. When patients were treated with levamisole, however, no clinical response was noted, although PMN movement improved in a number of cases.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson R., Glover A., Koornhof H. J., Rabson A. R. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol. 1976 Aug;117(2):428–432. [PubMed] [Google Scholar]
- Boxer L. A., Hedley-Whyte E. T., Stossel T. P. Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med. 1974 Nov 21;291(21):1093–1099. doi: 10.1056/NEJM197411212912101. [DOI] [PubMed] [Google Scholar]
- Chusid M. J., Gallin J. I., Dale D. C., Fauci A. S., Wolff S. M. Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. Pediatrics. 1976 Oct;58(4):513–520. [PubMed] [Google Scholar]
- Clark R. A., Kimball H. R. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest. 1971 Dec;50(12):2645–2652. doi: 10.1172/JCI106765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark R. A., Root R. K., Kimball H. R., Kirkpatrick C. H. Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med. 1973 Apr;78(4):515–519. doi: 10.7326/0003-4819-78-4-515. [DOI] [PubMed] [Google Scholar]
- De Cree J., Verhaegen H., De Cock W., Vanheule R., Brugmans J., Schuermans V. Letter: Impaired neutrophil phagocytosis. Lancet. 1974 Aug 3;2(7875):294–295. doi: 10.1016/s0140-6736(74)91464-0. [DOI] [PubMed] [Google Scholar]
- Edelson P. J., Stites D. P., Gold S., Fudenberg H. H. Disorders of neutrophil function. Defects in the early stages of the phagocytic process. Clin Exp Immunol. 1973 Jan;13(1):21–28. [PMC free article] [PubMed] [Google Scholar]
- Gallin J. I., Wolff S. M. Leucocyte chemotaxis: physiological considerations and abnormalities. Clin Haematol. 1975 Oct;4(3):567–607. [PubMed] [Google Scholar]
- Hill H. R., Estensen R. D., Hogan N. A., Quie P. G. Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis. J Lab Clin Med. 1976 Nov;88(5):796–806. [PubMed] [Google Scholar]
- Hoebeke J., Franchi G. Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc. 1973 Sep;14(3):317–323. [PubMed] [Google Scholar]
- Khan A. J., Evans H. E., Glass L., Skin Y. H., Almonte D. Defective neutrophil chemotaxis in patients with Down syndrome. J Pediatr. 1975 Jul;87(1):87–89. doi: 10.1016/s0022-3476(75)80077-1. [DOI] [PubMed] [Google Scholar]
- Lomnitzer R., Rabson A. R., Koornhof H. J. Leucocyte capillary migration: an adherence dependent phenomenon. Clin Exp Immunol. 1976 Aug;25(2):303–310. [PMC free article] [PubMed] [Google Scholar]
- Miller M. E., Norman M. E., Koblenzer P. J., Schonauer T. A new familial defect of neutrophil movement. J Lab Clin Med. 1973 Jul;82(1):1–8. [PubMed] [Google Scholar]
- Miller M. E., Oski F. A., Harris M. B. Lazy-leucocyte syndrome. A new disorder of neutrophil function. Lancet. 1971 Apr 3;1(7701):665–669. doi: 10.1016/s0140-6736(71)92679-1. [DOI] [PubMed] [Google Scholar]
- Rabson A. R., Whiting D. A., Anderson R., Glover A., Koornhof H. J. Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole. J Infect Dis. 1977 Jan;135(1):113–116. doi: 10.1093/infdis/135.1.113. [DOI] [PubMed] [Google Scholar]
- Rosenfeld S. I., Baum J., Steigbigel R. T., Leddy J. P. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum. J Clin Invest. 1976 Jun;57(6):1635–1643. doi: 10.1172/JCI108434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sher R., Anderson R., Rabson A. R., Koornhof H. J. Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J. 1974 Feb 9;48(6):209–212. [PubMed] [Google Scholar]
- Tripodi D., Parks L. C., Brugmans J. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. N Engl J Med. 1973 Aug 16;289(7):354–357. doi: 10.1056/NEJM197308162890707. [DOI] [PubMed] [Google Scholar]
- Van Scoy R. E., Hill H. R., Ritts R. E., Quie P. G. Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med. 1975 Jun;82(6):766–771. doi: 10.7326/0003-4819-82-6-766. [DOI] [PubMed] [Google Scholar]
- Ward P. A. Leukotaxis and leukotactic disorders. A review. Am J Pathol. 1974 Dec;77(3):520–538. [PMC free article] [PubMed] [Google Scholar]
- Witemeyer S., Van Epps D. E. A familial defect in cellular chemotaxis associated with redheadedness and recurrent infection. J Pediatr. 1976 Jul;89(1):33–37. doi: 10.1016/s0022-3476(76)80922-5. [DOI] [PubMed] [Google Scholar]
- Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]